![]() |
市場調查報告書
商品編碼
1742505
燙傷用軟膏的全球市場:各產品,燙傷的深度,各終端用戶,各地區,機會,預測,2018年~2032年Burn Ointment Market Assessment, By Product, By Depth of Burn, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
全球燒傷膏市場規模預計將從2024年的10.6億美元成長至2032年的16.8億美元,在2025-2032年的預測期內,複合年增長率為5.95%。由於燒傷治療技術的進步、燒傷相關損傷的增加以及對研究活動的日益關注,燒傷膏市場預計將繼續增長。根據美國消防局的數據,2023年火災受傷率最高的人口是50-74歲年齡段,而5-9歲的兒童最低。
全球燒傷膏市場正在經歷顯著增長,這主要是由於全球範圍內家庭和工業事故導致的燒傷人數增加。國際社會日益意識到及時妥善處理燒傷的重要性,進一步推動了燒傷需求的成長。更重要的是,持續的技術創新推動了高效燒傷膏的開發,這些膏藥具有先進的抗菌特性、理想的保濕度和再生成分,使消費者更傾向於天然活性成分和草本成分。同時,醫療保健設施(尤其是在新興經濟體)的發展和進步、醫療服務的便利性、醫療成本的上漲以及專業燒傷治療中心的蓬勃發展,使得先進的治療方法更加普及。人們對整體治療(包括最小化疤痕和功能恢復)的日益關注,以及消費者對輕度燒傷患者自我照顧的日益偏好,這些因素共同推動了全球燒傷膏市場的顯著增長。
此外,領先的研究機構正致力於開發新技術,以提高患者群體的護理品質。例如,根據2023年12月發表在 "國際免疫藥理學" 雜誌上的一篇論文,一個研究團隊引入了含有bFGF和VEGFA基因的血小板膜仿生奈米顆粒,以促進深度燒傷創面的癒合。 PM@gene-NP複合物給藥後,能夠有效地靶向燒傷創面。給予大鼠PM@gene-NP複合物後,燒傷創面的灌注得到促進,癒合速度比對照組更快。
本報告提供全球燙傷用軟膏市場相關調查,提供市場概要,以及各產品,按燙傷的深度,各終端用戶,各地區趨勢,及加入此市場的主要企業簡介等資訊。
Global burn ointment market is projected to witness a CAGR of 5.95% during the forecast period 2025-2032, growing from USD 1.06 billion in 2024 to USD 1.68 billion in 2032. The burn ointment market is expected to grow due to advancements in burn treatment technologies, increasing incidences of burn-related injuries, and rising focus on research activities. According to the United State Fire Administration, individuals between the ages of 50-74 had the highest fire injury rates and children between 5 and 9 years old the lowest rate of fire injury in 2023.
The global market for burn ointment has seen significant growth, driven chiefly by the rising worldwide prevalence of burn injuries through domestic accidents, and industrial accidents, among others. This enhanced requirement is further reinforced by a greater international awareness of the overriding need for the quick and proper management of burns. More importantly, ongoing technical innovations have resulted in the development of highly potent burn ointment with advanced antimicrobial properties, ideal moisture levels, and regenerative elements as well as a shifting preference on the part of consumers for naturally active and herbal elements. At the same time, the development and advancement of healthcare facilities and accessibility, especially in developing economies, as well as rising healthcare expenditure and growth in specialized burn care centers, are facilitating wider accessibility of advanced forms of treatment. Increasing focus on holistic healing involving minimum scarring and functional restoration and increased consumer preference for self-care in mild burn injury instances, all underpin the extensive growth in the market for burn ointment on a worldwide scale.
Additionally, leading research organizations are focusing on developing new technologies to improve the quality of care provided to the patient population. For instance, according to an article published in International Immunopharmacology in December 2023, a team of researchers introduced Biomimetic nanoparticles of the platelet membranes containing bFGF and VEGFA genes to enhance the healing of deep burn wounds. The PM@gene-NP complexes targeted the burn wounds efficiently upon their administration. The rats showed enhanced perfusion of the burn wounds as well as their faster healing compared to control groups after administration of the PM@gene-NP complexes.
Technology Advancement in Burn Care to Fuel the Market Demand for Burn Ointment
Technological progress has significantly changed burn care from a matter of simply enduring to making a big difference in patient outcomes and quality of life. Some of the important breakthroughs involve the evolution of hydrogel-based dressings and bioengineered skin replacements which promote optimum healing and diminish the requirement for autografts and advanced imaging techniques for accurate assessment of wounds. Nanotechnology and regenerative medicine hold promises of better infection control and faster tissue regeneration, and virtual reality holds the promise of non-pharmacological pain relief while caring for wounds. Additionally, critical care support has decreased mortality appreciably and novel laser innovations are redefining scar management, all contributing toward less painful, less traumatic and better cosmetically acceptable healing of burn injuries.
Various research and medical institutes across the globe are also focusing on the development of ointments that prevent partial thickness burns. For instance, the Vanderbilt University Medical Center is conducting an interventional study for investigating the efficacy and safety of an immunosuppressive agent (tacrolimus ointment) in patients suffering from deep partial-thickness burns. The study is estimated to conclude in December 2026.
Rising Cases of Fire Injury Boost Market Demand
The rising cases of fire injury resulting from domestic accidents, industrial hazards, road mishaps, and fire related incidents continuously boost the demand for effective burn care products. This trend is particularly prominent in low and middle-income countries, where infrastructure and safety protocols are often inadequate. As a result, there is a growing need for advanced burn ointments that promote faster healing, reduce infection risk, and improve patient outcomes. To decrease the fire injury cases the government also takes the initiative to promote safety precautions, quick fire exits practices by launching campaigns and fire exits programs. As per National Fire Protection Associations (NFPA) in 2023 about 1.39 million fires were responded to by local fire departments in the United States. An estimated 3,670 civilian fire fatalities and 13,350 civilian fire injuries resulted from these fires. Property losses due to these fires were about USD 23 billion.
Hospitals to Hold Major Market Share in the Burn Ointment Market
Hospitals command huge market share in the burn ointment market owing to several key factors. First, they remain the initial focal point of care for serious to critical burn injuries calling for specialized care in many instances involving a multi-specialty team as well as sophisticated facilities such as burn centers. Such serious injuries call for a volume and range of advanced burn ointments as well as prescription strengths and novel bioengineered skin constructs. Second, they enjoy bulk purchasing contracts and government-sponsored healthcare programs, whereby they can access the latest formulations at competitive prices. Thirdly, hospitals tend to be the initial adopters and pioneers of clinical innovations in the form of introducing them into clinical practice before they become mainstream available to consumers. And lastly, the prevalence of serious burn injuries calling for professional medical treatment and the inherent challenges in dealing with extensive burn wounds as well as infection prevention and healing stimulate the hospital segment's dominance in the burn ointment market. Additionally, to ensure that patients with burn injuries receive proper care and treatment, hospitals across the globe are focusing on adding separate burn wards. For instance, in May 2025, Bheri Hospital, Nepalgunj, Nepal established a burn ward with 6 beds and 14 beds surgical wing in its new building.
North America Dominates the Burn Ointment Market
North America is exerting its dominance in the burn ointment market. This region boasts well established healthcare systems, including specialized burn centers and hospital equipment with advanced and modern treatment facilities, including organization such as American Burn Association (ABA) and American College of Surgeon. The government and non-government organizations are increasing awareness and prevention by launching campaigns and spreading knowledge of first aid for burns, leading to improved access to quick burn treatment. Additionally, North America also has a strong presence of pharmaceutical and medical companies such as Johnson & Johnson Services, Inc., 3M Company and Pfizer Inc., which ensures steady product innovation, availability and marketing. For instance, in April 2025, AVITA Medical, Inc. presented 16 abstracts that showcased groundbreaking data related to wound and burn care at the American Burn Association (ABA) 2025 Annual Meeting in Arizona, United States.
Impact of U.S. Tariffs on Burn Ointment Market
U.S. tariffs have major implications for the global burn ointment market as they are raising costs of production and prices because of tariffs imposed on raw materials and final products. This creates supply chain breakdowns, which drive manufacturers to consider reshoring or nearshoring to enhance resilience at the expense of higher accompanying costs. Businesses also turn to stockpiling, which impacts inventory management. In the long run, such tariffs can restrict access and affordability of burn ointments, causing a change in global trade patterns and potentially affecting access to healthcare.
Key Players Landscape and Outlook
The worldwide burn ointment market has an intense rivalry between established medical and drug companies as well as innovative niche players. Dominant players utilize research and development efforts for innovative formulations in the form of biologics and nanotechnology and strategic acquisitions in a bid to gain market coverage and enhance portfolios. There's also increased emphasis on herbal and natural ingredients in a bid to address consumer demand. The outlook for the market remains optimistic on account of increasing burn injuries and ongoing advancements in wound care. Future directions involve ongoing development of regenerative therapies to reduce scarring and expansion of the biologics segment. The market will experience continued expansion through innovation, strategic alliances, and a shift toward delivering enhanced and easy burn care solutions.
Additionally, players are also focusing on launching new products. For instance, in March 2024, Integra Life Sciences Corporation introduces Micro Matrix Flex to make it easy to access hard-to-reach areas in complex procedures. Integra's UBM products - including Micro Matrix UBM Particulate and Cytal Wound Matrix sheets - have been used in more than 360,000 procedures over the past decade. This development resulted from close collaboration with surgeons to address significant treatment challenges and establish a new level of care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.